• Beximco Completes Sanofi Bangladesh Acquisition

News & Views

Beximco Completes Sanofi Bangladesh Acquisition

Nov 17 2021

Beximco Pharmaceuticals Ltd has announced that the company has now completed its acquisition of the majority stake in Sanofi Bangladesh, in line with the company’s strategy to expand core capabilities and product offerings.

Mr Nazmul Hassan MP, Beximco Pharma MD, commented: "The completion of this deal - the second acquisition in Beximco Pharma’s history - is a significant moment. We have a clear strategy to continue our diversification and expansion while strengthening our position as a market-leading pharma company in Bangladesh. The acquisition of a majority stake in Sanofi Bangladesh is precisely in line with this strategy, strengthening our position in key therapeutic areas to drive sustainable revenue and profit growth. We look forward to welcoming over 800 skilled and diligent Sanofi Bangladesh employees to our existing workforce. As an enlarged group, we are excited to continue our growth trajectory by delivering affordable treatments and breakthrough therapies in our growing domestic market."

More information online


Digital Edition

Labmate UK & Ireland November 2021

November 2021

In This Edition Articles - Advancements in Freeze drying production and the impacts on scale, sustainability and compliance - Face-to-face events finally start up - But how will attendance f...

View all digital editions

Events

Euromedlab 2021 - POSTPONED

Nov 28 2021 Munich, Germany

Lab Asia 2021 - POSTPONED TO 2022

Nov 30 2021 Virtual event

Pharma Asia - NEW DATES

Dec 08 2021 Islamabad, Pakistan

LABWorld China 2021

Dec 16 2021 SNIEC Shanghai, China & online

View all events